study
-
Spine
Orthobond Supports Hospital for Special Surgery’s Presentation of New Landmark Study on Bacteria in Patients Undergoing Lumbar Spine Surgery at 2024 NASS Annual Meeting
This study reinforces the risk bacteria poses on the safety and wellbeing of patients in the surgical room and the…
Read More » -
Spine
Cutting-Edge Endoscopic Spine Surgery Reduces Need for Post-Op Pain Medication
Decreased opioid medication use by 21 percent compared to other minimally-invasive spine surgical techniques NEW YORK, Sept. 20, 2024 /PRNewswire/ — An…
Read More » -
Sports Medicine
Sparta Biomedical Reports Treatment of First Patients with Breakthrough Device, Ormi
MORRISVILLE, N.C., Sept. 17, 2024 /PRNewswire/ — Sparta Biomedical, a private medical device company focused on osteoarthritis repair solutions, today announced that…
Read More » -
Spine
Life Spine Announces Published Article on Discectomy Performance During Transforaminal Lumbar Interbody Fusion Approach Using Endoscopic Technique vs MIS Tubular Approach
HUNTLEY, Ill., September 17, 2024–(BUSINESS WIRE)–Life Spine, Inc., a medical device company that designs, develops, manufactures and markets products for…
Read More » -
Recon
Maxx Orthopedics, in Partnership with Invibio Biomaterial Solutions, Secures US IDE Approval for PEEK-OPTIMA™ Total Knee Arthroplasty Study
The PEEK-OPTIMA femoral component is based on Maxx Orthopedics’ Freedom Total Knee System high-flexion, bone-conserving design. The study will compare…
Read More » -
Spine
Innovasis Landmark Study on Spinal Fusion Published in Top Spine Journal
Salt Lake City, Utah, August 22, 2024 – OrthoSpineNews Innovasis, a leading innovator in bioactive spine surgery solutions, is proud…
Read More » -
Spine
DiscGenics Announces the International Journal of Spine Surgery Has Published Results from an FDA-Approved Study of an Allogeneic Disc Progenitor Cell Therapy for the Treatment of Adults with Lumbar Disc Degeneration
SALT LAKE CITY, July 9, 2024 /PRNewswire/ — DiscGenics, Inc., a privately held, late-stage clinical, biopharmaceutical company developing allogeneic, cell-based, regenerative therapies for…
Read More » -
Spine
Landmark Study Shows Lumbar Facet Arthroplasty Superior to Fusion for Spinal Stenosis and Spondylolisthesis
Tim Allen, June 26th, 2024, OrthoSpineNews – A study published in the Journal of Bone and Joint Surgery has found…
Read More » -
Recon
Exactech Presents New Research Showcasing AI Platform’s Accuracy, Reliability and Performance
GAINESVILLE, Fla., June 26, 2024 /PRNewswire/ — Exactech, a global medical technology leader, presented new research that showcases the accuracy, reliability and performance…
Read More » -
Biologics
Biogennix Announces Publication of a Scientific Study on Its Advanced Bone Graft Technology
IRVINE, Calif., June 12, 2024 – OrthoSpineNews – Biogennix, an osteobiologics company specializing in products for bone graft procedures, has…
Read More » -
Spine
Facet Replacement FDA Study Garners Best Paper Award At Lumbar Spine Research Society Meeting
Premia Spine’s study on the TOPS® System, showcasing its advantages over traditional lumbar fusion, received the Best Paper award at the…
Read More » -
Recon
New Study from HSS Reveals Minimally Invasive Procedure Can Delay Arthritis in Select Patients with Hip Impingement
First Study to Demonstrate Longer-Term Benefits of Modern Hip Arthroscopy Techniques NEW YORK, April 18, 2024 /PRNewswire/ — A new study by surgeon-scientists…
Read More » -
Regulatory
Lipogems Announces Last Patient Enrolled in the U.S. FDA IDE Arise Study for the Treatment of Knee Osteoarthritis
Orthopaedic surgeon, Dr. Cristin Mathew, enrolls a patient in the Lipogems ARISE US FDA IDE Knee OA Study ATLANTA, April 10,…
Read More » -
Regulatory
Lipogems Announces First Patient Enrolled in the Second U.S. FDA IDE Study for the Treatment of Knee Osteoarthritis
Orthopaedic surgeon, Dr. Yogesh Mittal, enrolls the first patient in the ARISE 2 Study for Knee Osteoarthritis ATLANTA, April 8, 2024 /PRNewswire/…
Read More » -
Spine
BioRestorative Therapies Partners with Galen Patient Recruitment to Accelerate Completion of Enrollment in Phase 2 Trial of BRTX-100 in Chronic Lumbar Disc Disease
— Collaboration follows recent manufacturing/clinical process enhancements that have tripled monthly trial capacity — — Patient enrollment expected to be…
Read More »